Brennan M F, Jensen R T, Wesley R A, Doppman J L, McCarthy D M
Ann Surg. 1982 Sep;196(3):239-45. doi: 10.1097/00000658-198209000-00002.
From 1975 to 1981, the authors' deliberate intent was to treat all patients with Zollinger-Ellison syndrome (ZES) medically. This allowed the authors to ask the question of the need for surgical intervention in patients managed medically. Twenty-six patients followed for an average of 37 months (range 2 to 147 months) from diagnosis were maintained on cimetidine for a mean of 32 months (2 to 64 months). Six of these patients (23%) were unable to be maintained on cimetidine and required surgery during this period. Four received total gastrectomy, and two had lesser operations. Analysis of survival curves in this small group does not illustrate a difference between outcome based on surgical or medical management. Prospective studies based on aggressive attempts at preoperative localization with staging laparotomy and tumor resection seem justified.
1975年至1981年期间,作者有意采用药物治疗所有佐林格-埃利森综合征(ZES)患者。这使作者能够探讨对于接受药物治疗的患者是否需要进行手术干预的问题。从诊断开始平均随访37个月(范围为2至147个月)的26例患者接受西咪替丁治疗,平均治疗时间为32个月(2至64个月)。在此期间,其中6例患者(23%)无法继续使用西咪替丁治疗而需要接受手术。4例接受了全胃切除术,2例接受了较小的手术。对这个小群体生存曲线的分析并未显示出手术治疗或药物治疗在结果上的差异。基于术前积极定位、分期剖腹探查和肿瘤切除的前瞻性研究似乎是合理的。